Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Total Current Assets
Vivos Therapeutics Inc
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Total Current Assets
$2.5m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Total Current Assets
$3.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Current Assets
$2.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
CVS Health Corp
NYSE:CVS
|
Total Current Assets
$67.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Total Current Assets
$43.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Current Assets
$3.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
See Also
What is Vivos Therapeutics Inc's Total Current Assets?
Total Current Assets
2.5m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Total Current Assets amounts to 2.5m USD.
What is Vivos Therapeutics Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
4%
Over the last year, the Total Current Assets growth was -55%. The average annual Total Current Assets growth rates for Vivos Therapeutics Inc have been -51% over the past three years , 4% over the past five years .